Endothelial progenitor cells: what use for the cardiologist?

A Siddique, Eduard Shantsila, Gregory Lip, Chetan Varma

Research output: Contribution to journalArticle

32 Citations (Scopus)


ABSTRACT: Endothelial Progenitor Cells (EPC) were first described in 1997 and have since been the subject of numerous investigative studies exploring the potential of these cells in the process of cardiovascular damage and repair. Whilst their exact definition and mechanism of action remains unclear, they are directly influenced by different cardiovascular risk factors and have a definite role to play in defining cardiovascular risk. Furthermore, EPCs may have important therapeutic implications and further understanding of their pathophysiology has enabled us to explore new possibilities in the management of cardiovascular disease. This review article aims to provide an overview of the vast literature on EPCs in relation to clinical cardiology.
Original languageEnglish
Pages (from-to)6
Number of pages1
JournalJournal of angiogenesis research
Publication statusPublished - 1 Jan 2010


Dive into the research topics of 'Endothelial progenitor cells: what use for the cardiologist?'. Together they form a unique fingerprint.

Cite this